Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

regorafenib MeSH Supplementary Concept Data 2025


MeSH Supplementary
regorafenib
Unique ID
C559147
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C559147
Entry Term(s)
4-(4-(((4-chloro-3-(trifluoromethyl)phenyl)carbamoyl)amino)-3-fluorophenoxy)-n-methylpyridine-2-carboxamide
BAY 73-4506
BAY-73-4506
BAY73-4506
Stivarga
Registry Numbers
24T2A1DOYB
Heading Mapped to
*Phenylurea Compounds
*Pyridines
Frequency
803
Note
has both antiangiogenic and antineoplastic activities; structure in first source
Source
Int J Cancer 2011 Jul 1;129(1):245-55
Date of Entry
2011/07/03
Revision Date
2017/01/30
regorafenib Preferred
BAY 73-4506 Narrower
Stivarga Related
page delivered in 0.005s